- Home
- OB vs KOD Comparison
OB vs KOD Comparison
Compare OB & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OB
- KOD
- Stock Information
- Founded
- OB 2006
- KOD 2009
- Country
- OB United States
- KOD United States
- Employees
- OB N/A
- KOD N/A
- Industry
- OB Industrial Machinery/Components
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OB Industrials
- KOD Health Care
- Exchange
- OB Nasdaq
- KOD Nasdaq
- Market Cap
- OB 441.8M
- KOD 454.7M
- IPO Year
- OB 2021
- KOD 2018
- Fundamental
- Price
- OB $4.16
- KOD $3.65
- Analyst Decision
- OB Buy
- KOD Hold
- Analyst Count
- OB 6
- KOD 4
- Target Price
- OB $6.80
- KOD $8.00
- AVG Volume (30 Days)
- OB 486.1K
- KOD 308.6K
- Earning Date
- OB 02-27-2025
- KOD 03-27-2025
- Dividend Yield
- OB N/A
- KOD N/A
- EPS Growth
- OB N/A
- KOD N/A
- EPS
- OB N/A
- KOD N/A
- Revenue
- OB $889,875,000.00
- KOD N/A
- Revenue This Year
- OB $44.29
- KOD N/A
- Revenue Next Year
- OB N/A
- KOD N/A
- P/E Ratio
- OB N/A
- KOD N/A
- Revenue Growth
- OB N/A
- KOD N/A
- 52 Week Low
- OB $3.58
- KOD $2.19
- 52 Week High
- OB $7.87
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- OB 24.75
- KOD 28.91
- Support Level
- OB $3.89
- KOD $3.42
- Resistance Level
- OB $4.41
- KOD $3.85
- Average True Range (ATR)
- OB 0.41
- KOD 0.36
- MACD
- OB -0.18
- KOD 0.05
- Stochastic Oscillator
- OB 8.63
- KOD 13.14
About OB Outbrain Inc.
Outbrain Inc is a platform powering the open web that matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. It derives revenue from advertisers through user engagement with the ads that it places on media partners' web pages and mobile applications. The company has its geographic presence in Europe, the Middle East, and Africa followed by the USA and others.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.